Suggestions

Du même auteur

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

Archive ouverte | Gennari, A. | CCSD

International audience

Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?

Archive ouverte | Valenza, C. | CCSD

International audience. For patients with hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative (HR+/HER2−) metastatic breast cancer (mBC) progressed on first-line endocrine therapy plus...

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

Archive ouverte | Belli, C. | CCSD

International audience. Aberrant activation of RET is a critical driver of growth and proliferation in diverse solid tumours. Multikinase inhibitors (MKIs) showing anti-RET activities have been tested in RET-altered...

Chargement des enrichissements...